SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000944809-22-000023
Filing Date
2022-05-09
Accepted
2022-05-09 16:07:15
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20220509.htm   iXBRL 8-K 40003
2 EX-99.1 exhibit991q1225922.htm EX-99.1 72072
6 image_0a.jpg GRAPHIC 260383
  Complete submission text file 0000944809-22-000023.txt   617312

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220509.xsd EX-101.SCH 1929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220509_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220509_pre.xml EX-101.PRE 12538
8 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220509_htm.xml XML 10812
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 22904918
SIC: 2834 Pharmaceutical Preparations